Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Mirion Technologies, Inc. | Medical Group President | Class A Common Stock | 116K | $1.21M | $10.45 | Nov 1, 2023 | Direct |
Y-mAbs Therapeutics, Inc. | PRESIDENT & CEO, Director | Common Stock | 35.7K | $71.4K | $2.00 | Feb 12, 2024 | Direct |
Y-mAbs Therapeutics, Inc. | PRESIDENT & CEO, Director | Employee Stock Option (right to buy) | 214K | Feb 12, 2024 | Direct | ||
Y-mAbs Therapeutics, Inc. | PRESIDENT & CEO, Director | Restricted Stock Units | 54K | Feb 12, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
YMAB | Y-mAbs Therapeutics, Inc. | Feb 12, 2024 | 3 | $0 | 4 | Feb 14, 2024 | PRESIDENT & CEO, Director |
YMAB | Y-mAbs Therapeutics, Inc. | Nov 6, 2023 | 1 | $0 | 4 | Nov 8, 2023 | President and CEO, Director |
YMAB | Y-mAbs Therapeutics, Inc. | Nov 6, 2023 | 0 | $0 | 3 | Nov 8, 2023 | President & CEO, Director |
MIR | Mirion Technologies, Inc. | Nov 1, 2023 | 1 | -$38.2K | 4 | Nov 3, 2023 | Medical Group President |
MIR | Mirion Technologies, Inc. | Mar 29, 2023 | 1 | $0 | 4 | Mar 31, 2023 | Medical Group President |
MIR | Mirion Technologies, Inc. | Nov 1, 2022 | 1 | $0 | 4 | Nov 3, 2022 | Medical Group President |
MIR | Mirion Technologies, Inc. | Oct 3, 2022 | 0 | $0 | 3 | Oct 6, 2022 | Medical Group President |